|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn811410335 |
003 |
OCoLC |
005 |
20231117044744.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
111102s2012 caua ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d UIU
|d N$T
|d OCLCF
|d TEFOD
|d YDXCP
|d TEFOD
|d OCLCQ
|d MHW
|d DEBSZ
|d OCLCQ
|d D6H
|d CNCGM
|d WYU
|d OL$
|d UKBTH
|d SFB
|d VT2
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 811490999
|a 1127207699
|a 1235836908
|
020 |
|
|
|a 9780124017467
|q (electronic bk.)
|
020 |
|
|
|a 0124017460
|q (electronic bk.)
|
020 |
|
|
|z 9780123984593
|
020 |
|
|
|a 1283575256
|
020 |
|
|
|a 9781283575256
|
020 |
|
|
|a 9786613887702
|
020 |
|
|
|a 6613887706
|
020 |
|
|
|a 0123984599
|
020 |
|
|
|a 9780123984593
|
035 |
|
|
|a (OCoLC)811410335
|z (OCoLC)811490999
|z (OCoLC)1127207699
|z (OCoLC)1235836908
|
050 |
|
4 |
|a QH588.S83
|b G46 2012eb
|
072 |
|
7 |
|a MED
|x 106000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.02774
|2 23
|
245 |
0 |
0 |
|a Genetics of stem cells.
|n Part A /
|c edited by Yaoliang Tang.
|
260 |
|
|
|a San Diego :
|b Elsevier,
|c 2012.
|
300 |
|
|
|a 1 online resource (xvi, 367 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Progress in molecular biology and translational science ;
|v 111
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a Genetics of Stem Cells.
|
505 |
0 |
|
|a Front Cover; Genetics of Stem Cells, Part A; Copyright; Contents; Contributors; Preface; Chapter 1: Generation of Induced Pluripotent Stem Cells from Somatic Cells; I. Generation of iPSCs; II. Methods of Delivering Transcription Factors into Cells; A. Integrating Viral Vectors; B. Nonintegrating Viral Vectors; C. Nonviral Reprogramming; D. Recombinant Proteins of Transcription Factors; E. Synthetic Modified mRNA of Transcription Factors; F. microRNAs; III. Nongenetic Approaches for Reprogramming; A. Small Molecules; B. Altering Cell-Cycle Signal Pathways
|
505 |
8 |
|
|a IV. Generation of Human iPSCs from Different Somatic Cell TypesV. Characterization of iPSCs; A. Genomic Integrity; B. Gene Expression Profiles; C. Epigenetic Status; D. Developmental Potential: Pluripotency; E. Differences Between iPSCs and ESCs; VI. Conclusion; References; Chapter 2: Induced Pluripotent Cells in Cardiovascular Biology: Epigenetics, Promises, and Challenges; I. Introduction; II. Non-iPS-Cell-Based Therapies and Their Limitations; A. Autologous Adult Bone-Marrow-Derived Stem Cells for Myocardial Repair; III. Therapeutic Cloning and Embryonic Stem Cells
|
505 |
8 |
|
|a IV. Induced Pluripotent Stem cells from Differentiated Somatic CellsA. Generation of iPS Cells; B. Epigenetic Mechanisms of Induced Pluripotency; V. Cardiovascular Lineage Differentiation of iPS Cells; A. Applications of iPS Cells; B. Major Limitations and Challenges for Clinical Application of iPS Cells; References; Chapter 3: Reprogramming of Somatic Cells; I. Introduction; II. Reprogramming of Somatic Cells into Pluripotent Stem Cells; A. Oocyte-Dependent Nuclear Reprogramming; 1. Somatic Cell Nuclear Transfer; B. Oocyte-Independent Nuclear Reprogramming; 1. Cell Fusion
|
505 |
8 |
|
|a 2. Somatic Cell Reprogramming by Transcription Factors (iPS cells)a. Methods of iPS Cell Generation; i. Viral-Integration-Based Gene Delivery System; ii. Viral-Nonintegration-Based Gene Delivery System; iii. Nonviral Vector Method of iPS Cells; iv. ESC Extract iPS Cells; v. Chemically Induced Pluripotent Stem Cells; vi. miRNA-Induced iPS Cells; 3. Cell Type and Reprogramming Efficiency; 4. Epigenetic Reprogramming Mechanism of iPS Cells; 5. Molecular Mechanism of Reprogramming; C. Incomplete Programming; D. Direct Reprogramming of Specific Lineage; 1. Immunogenicity of iPS Cells
|
505 |
8 |
|
|a III. Future PerspectivesReferences; Chapter 4: Induction of Somatic Cell Reprogramming Using the MicroRNA miR-302; I. Introduction; II. Mechanism of Reprogramming; A. MicroRNA and Reprogramming; B. Mechanism of miR-302 Biogenesis; C. miR-302 Induces Global Demethylation; D. miR-302 Activates Oct4 Expression; III. Role of miR-302 in Early Embryogenesis; A. MicroRNA and Zygotic Development; B. Comparison Between SCR-Mediated Global Demethylation and Zygotic Demethylation; IV. Dual Role of miR-302: Reprogramming Effector and Tumor Suppressor; A. Pluripotency Versus Tumorigenicity: Mechanism
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Stem cells.
|
650 |
|
0 |
|a Genetics.
|
650 |
|
2 |
|a Stem Cells
|0 (DNLM)D013234
|
650 |
|
2 |
|a Genetics
|0 (DNLM)D005823
|
650 |
|
6 |
|a Cellules souches.
|0 (CaQQLa)201-0058821
|
650 |
|
6 |
|a G�en�etique.
|0 (CaQQLa)201-0069234
|
650 |
|
7 |
|a genetics.
|2 aat
|0 (CStmoGRI)aat300138822
|
650 |
|
7 |
|a MEDICAL
|x Research.
|2 bisacsh
|
650 |
|
7 |
|a Genetics
|2 fast
|0 (OCoLC)fst00940117
|
650 |
|
7 |
|a Stem cells
|2 fast
|0 (OCoLC)fst01132975
|
700 |
1 |
|
|a Tang, Yaoliang.
|
776 |
0 |
8 |
|i Print version:
|z 9780123984593
|
830 |
|
0 |
|a Progress in molecular biology and translational science ;
|v 111.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123984593
|z Texto completo
|